Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q3

3055.TEDINET S100Q3RS
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥198.6bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥248.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥188.6bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥2.2bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥1.7bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥3.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥3.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.7bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥3.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥3.0bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥2.1bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥146.6bnat 2022-12-31Cons.Assets
Total assets¥136.9bnat 2022-03-31Cons.Assets
Total assets¥142.2bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥89.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥81.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥57.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥55.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥55.5bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥21.4bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥21.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥21.4bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥20.7bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥20.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥3.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥856m2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥491m2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥808m2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥849m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥824m2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥109.942022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.722022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.442021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.42021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.442021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio39.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio40.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-12-31¥1.9bn
Otherother segmentsrevenue external2022-04-01 → 2022-12-31¥46m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥1.8bn
Otherother segmentssegment profit2022-04-01 → 2022-12-31¥819m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31−¥14m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥362m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥825m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥25m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥49.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥48.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥379m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥295m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥143.0bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥136.1bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.9bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥208.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥198.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥9.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥3.3bn
Otherother segmentsrevenue2021-04-01 → 2021-12-31¥1.3bn
Otherother segmentsrevenue external2021-04-01 → 2021-12-31¥45m
Otherother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥1.2bn
Otherother segmentssegment profit2021-04-01 → 2021-12-31¥264m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥10.3bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥10.3bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥10m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥122m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥1.0bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥331m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥700m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥60m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥47.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥46.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥350m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥875m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥2.9bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥2.8bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥6m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥272m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2021-04-01 → 2021-12-31¥135.0bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2021-04-01 → 2021-12-31¥128.2bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥6.8bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2021-04-01 → 2021-12-31¥577m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥197.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥188.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥9.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥2.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 514
ItemContextValueUnit
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember2431800
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember21953300
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember219533
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember14900
Number of shares issued shares voting rightsCurrentQuarterInstant24400000
Number of voting rights issued shares voting rightsCurrentQuarterInstant219533
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member2431800
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member2431800
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0997
Number of shares held in own name treasury shares etcCurrentQuarterInstant2431800
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant2431800
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0997
Cash and depositsPrior1YearInstant21091000000JPY
Cash and depositsCurrentQuarterInstant21377000000JPY
Notes and accounts receivable tradePrior1YearInstant52740000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant58778000000JPY
Merchandise and finished goodsPrior1YearInstant15974000000JPY
Merchandise and finished goodsCurrentQuarterInstant18555000000JPY
Work in processPrior1YearInstant3000000JPY
Work in processCurrentQuarterInstant6000000JPY
Other caPrior1YearInstant7706000000JPY
Other caCurrentQuarterInstant7973000000JPY
Allowance for doubtful accounts caPrior1YearInstant-20000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-16000000JPY
Current assetsPrior1YearInstant97495000000JPY
Current assetsCurrentQuarterInstant106675000000JPY
Buildings and structures netPrior1YearInstant7844000000JPY
Buildings and structures netCurrentQuarterInstant9423000000JPY
LandPrior1YearInstant9421000000JPY
LandCurrentQuarterInstant9916000000JPY
Construction in progressPrior1YearInstant2301000000JPY
Construction in progressCurrentQuarterInstant609000000JPY
Other net ppePrior1YearInstant852000000JPY
Other net ppeCurrentQuarterInstant819000000JPY
Property plant and equipmentPrior1YearInstant20420000000JPY
Property plant and equipmentCurrentQuarterInstant20769000000JPY
GoodwillPrior1YearInstant1069000000JPY
GoodwillCurrentQuarterInstant988000000JPY
SoftwarePrior1YearInstant541000000JPY
SoftwareCurrentQuarterInstant491000000JPY
Other iaPrior1YearInstant186000000JPY
Other iaCurrentQuarterInstant297000000JPY
Intangible assetsPrior1YearInstant1797000000JPY
Intangible assetsCurrentQuarterInstant1777000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass